Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank14
3Y CAGR-9.0%
5Y CAGR-14.7%
Year-over-Year Change
Return on equity
3Y CAGR
-9.0%/yr
vs -9.0%/yr prior
5Y CAGR
-14.7%/yr
Recent acceleration
Acceleration
-0.0pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 14.41% | -4.1% |
| 2024 | 15.03% | -1.2% |
| 2023 | 15.22% | -20.5% |
| 2022 | 19.14% | -55.5% |
| 2021 | 43.03% | +35.0% |
| 2020 | 31.86% | +67.0% |
| 2019 | 19.08% | -31.6% |
| 2018 | 27.91% | +43.1% |
| 2017 | 19.51% | -3.1% |
| 2016 | 20.13% | - |